Evidence map›Paper›PMID 26956766›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2016

CD200Fc reduces TLR4-mediated inflammatory responses in LPS-induced rat primary microglial cells via inhibition of the NF-κB pathway.

Li Jiang, Fan Xu, Wenjing He, Lifei Chen, Haibin Zhong, Yu Wu, Siming Zeng, Li Li, Min Li

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Anti-angiogenic and anti-inflammatory effects of CD200-CD200R1 axis in oxygen-induced retinopathy mice model.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Article
  14. Article
  15. CD200 ModulatesInternational journal of molecular sciences · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Li JiangDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China.
Fan XuDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China.
Wenjing HeDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China.
Lifei ChenDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China.
Haibin ZhongDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China.
Yu WuDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China.
Siming ZengDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China. eyezsm@163.com.
Li LiDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China.
Min LiDepartment of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, No. 6, Taoyuan Road, Nanning, 530021, Guangxi, People's Republic of China. eyeminli@163.com.
The People's Hospital of Guangxi Zhuang Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBased on recent information, CD200Fc, a CD200R1 agonist, could attenuate the inflammatory response of microglial cells in autoimmune diseases and neuro-degeneration. However, the exact molecular mechanisms responsible for the anti-inflammatory activity of CD200Fc in microglial cells have not been elucidated. In the present study, we investigated the anti-inflammatory effects and the molecular mechanisms of CD200Fc in lipopolysaccharide (LPS)-stimulated rat primary microglial cells.

methodsThe cell viability was measured by MTT assay. The LPS-induced cytokines release (IL-1β, IL-6, TNF-α, iNOS, MCP-1, and COX-2) was monitored by ELISA or real-time PCR, while NF-κB-related signals (MyD88, p-TAK1, TRIF, p-TBK1, p-IRF3, p-IκB, and NF-κB-P65) were assessed by real-time PCR, western blot and/or Immunofluorescent staining.

resultsCD200Fc and/or LPS exerted no significant cytotoxicity on microglial cells. LPS reduced the CD200R1 expression in microglial cells, and this effect was attenuated by CD200Fc. In addition, CD200Fc inhibited LPS-induced expression of TLR4 and its adapter molecules (MyD88 and p-TAK1, TRIF, p-TBK1, and p-IRF3), and abolished its interactions with MyD88, TAK1, and TRIF in microglial cells. CD200Fc also attenuated LPS-induced protein expression of p-IκB and NF-κB-P65 translocation to nucleus in microglial cells. Moreover, CD200Fc suppressed the LPS-induced release of inflammatory mediators in microglial cells, including IL-1β, IL-6, TNF-α, iNOS, MCP-1, and COX-2.

conclusionThese results indicated that CD200Fc displayed an anti-inflammatory effect in LPS-induced microglial cells by blocking TLR4-mediated NF-κB activation.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsAnti-Inflammatory AgentsCells, CulturedCell SurvivalCytokinesImmunoglobulin GLipopolysaccharidesMicrogliaMyeloid Differentiation Factor 88NF-kappa BRats, Sprague-DawleyReceptors, ImmunologicSignal TransductionToll-Like Receptor 4Adaptor Proteins, Vesicular TransportAnti-Inflammatory AgentsCD200-FC, mouseCd200 protein, ratCytokinesImmunoglobulin GLipopolysaccharidesMyeloid Differentiation Factor 88NF-kappa BReceptors, ImmunologicTicam1 protein, ratTlr4 protein, ratToll-Like Receptor 4CD200FcInflammatory responsesMicroglial cellsNF-κBTLR4

Identifiers

PMID26956766
OpenAlexW2295298792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.